Teva Pharma (TEVA) PT Lowered to $20 at Wells Fargo
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $36.77 +0.68%
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Rating Summary:
17 Buy, 22 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Join SI Premium – FREE
Wells Fargo analyst David Maris lowered the price target on Teva Pharma (NYSE: TEVA) to $20.00 (from $24.00) while maintaining a Market Perform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- Hapag-Lloyd AG (HLAG:GR) (HPGLY) PT Raised to EUR115 at Citi
- Citi Upgrades Central Retail Corp PCL (CRC:TB) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Wells Fargo, David MarisSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
